NDLI: Combination anticoagulant and antiplatelet therapy in atrial fibrillation patients.

Please wait, while we are loading the content...

Combination anticoagulant and antiplatelet therapy in atrial fibrillation patients.

Content Provider	Semantic Scholar
Author	Lane, Deirdre A.
Copyright Year	2009
Abstract	The question of whether or not combination antithrombotic therapy is beneficial in terms of a reduction in fatal and non-fatal vascular events in atrial fibrillation (AF) is an important question which essentially remains unanswered. Original randomised controlled trials in AF patients examining the efficacy of combination oral anticoagulant (OAC) and antiplatelet therapy for stroke prevention in AF, by comparing either fixed dose (or low intensity international normalized ratio, INR, <1.5) anticoagulation plus aspirin with dose-adjusted warfarin (INR, 2.0-3.0), or dose-adjusted warfarin ± aspirin, have not reported any additional benefit of fixed dose (or low intensity) anticoagulation plus aspirin over dose-adjusted warfarin alone. 1 The Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events (ACTIVE)-W trial also showed that anticoagulation with dose-adjusted warfarin (INR, 2.0-3.0) was superior to the combination of clopidogrel plus aspirin for the prevention of vascular events in patients with AF at high risk of stroke, particularly in those
File Format	PDF HTM / HTML
Alternate Webpage(s)	http://appswl.elsevier.es/watermark/ctl_servlet?_f=10&accion=L&anuncioPdf=ERROR_publi_pdf&fichero=255v62n09a13141951pdf001.pdf&lan=en&origen=cardio&pcontactid=&pident_articulo=13141951&pident_revista=255&pident_usuario=0&ty=88&web=www.revespcardiol.org
PubMed reference number	19712617v1
Volume Number	62
Issue Number	9
Journal	Revista espanola de cardiologia
Language	English
Access Restriction	Open
Subject Keyword	Aspirin Atrial Fibrillation Cerebrovascular Disorders Cerebrovascular accident Heart Atrium High Risk Acute Leukemia International Normalized Ratio Patients Ventricular Fibrillation Warfarin clopidogrel irbesartan oral anticoagulants
Content Type	Text
Resource Type	Article

Central Library (ISO-9001:2015 Certified)
Indian Institute of Technology Kharagpur
Kharagpur, West Bengal, India | PIN - 721302

See location in the Map
03222 282435
Mail: support@ndl.gov.in

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in